Pancreatic Cancer Research

ResearcherInstituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránActive in the last 2 years

Fidel David Huitzil Melendez

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4143-9186; OpenAlex author ID A5011450963. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2020: 1 trial · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 1

  1. Neoadjuvant CAN-2409 plus Prodrug in Combination with Standard of Care Chemoradiation for Borderline Resectable Pancreatic Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-5183420/v1↗

Trials 1

  1. Germline Mutations Associated With Hereditary Pancreatic Cancer in Unselected Patients With Pancreatic Cancer in Mexico Principal investigator NCT05305001↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. W. Garrett Nichols · 1 shared paper, 2024 · strength 0.22
  2. Paul Peter Tak · 1 shared paper, 2024 · strength 0.22
  3. Mark Bloomston · 1 shared paper, 2024 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.